Olaf Joens

This inventor holds 9 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, Other. Active years: 2014-2024.

USPTO Granted Patents = 9

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 33(Granted Patents)

Location History:

Gau-Algesheim, DE (2015)
Ingelheim, DE (2016)
Ober-Hilbersheim, DE (2014 - 2024)

Company Filing History:

5 out of 317

Boehringer Ingelheim Vetmedica Gmbh

patents

3 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12011441 - Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease (2024-06-18),

2. 11413285 - PDE III inhibitors for treatment of asymptomatic heart failure (2022-08-16),

3. 10537588 - Use of pimobendan for the reduction of heart size in mammals suffering from heart failure (2020-01-21),

4. 10537570 - Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease (2020-01-21),

5. 10117869 - PDE III inhibitors for treatment of asymptomatic heart failure (2018-11-06),

6. 9889148 - Use of pimobendan for the reduction of heart size in mammals suffering from heart failure (2018-02-13),

7. 9463199 - Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure (2016-10-11),

8. 8980894 - Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure (2015-03-17),

9. 8664252 - [object Object] (2014-03-04),

This text is generated by artificial intelligence and may not be accurate.